BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 33540386)

  • 1. Rational nanocarrier design towards clinical translation of cancer nanotherapy.
    Guo D; Ji X; Luo J
    Biomed Mater; 2021 Mar; 16(3):. PubMed ID: 33540386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Acidity-Cleavable Maleic Acid Amide (TACMAA): A Powerful Tool for Designing Smart Nanoparticles To Overcome Delivery Barriers in Cancer Nanomedicine.
    Du JZ; Li HJ; Wang J
    Acc Chem Res; 2018 Nov; 51(11):2848-2856. PubMed ID: 30346728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Advancement and Obstacles in Improving the Stability of Nanocarriers for Precision Drug Delivery in the Field of Nanomedicine.
    Mahajan K; Bhattacharya S
    Curr Top Med Chem; 2024; 24(8):686-721. PubMed ID: 38409730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stealth Nanocarriers in Cancer Therapy: a Comprehensive Review of Design, Functionality, and Clinical Applications.
    Saadh MJ; Mustafa MA; Kumar A; Alamir HTA; Kumar A; Khudair SA; Faisal A; Alubiady MHS; Jalal SS; Shafik SS; Ahmad I; Khry FAF; Abosaoda MK
    AAPS PharmSciTech; 2024 Jun; 25(6):140. PubMed ID: 38890191
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanocarrier-Based Therapeutics and Theranostics Drug Delivery Systems for Next Generation of Liver Cancer Nanodrug Modalities.
    Ruman U; Fakurazi S; Masarudin MJ; Hussein MZ
    Int J Nanomedicine; 2020; 15():1437-1456. PubMed ID: 32184597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Silica-Based Nanoparticles for Biomedical Applications: From Nanocarriers to Biomodulators.
    Yang Y; Zhang M; Song H; Yu C
    Acc Chem Res; 2020 Aug; 53(8):1545-1556. PubMed ID: 32667182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recent Advances in Paclitaxel-based Self-Delivery Nanomedicine for Cancer Therapy.
    Zhou M; Han S; Aras O; An F
    Curr Med Chem; 2021; 28(31):6358-6374. PubMed ID: 33176629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent trends of nanomedicinal approaches in clinics.
    Dilnawaz F; Acharya S; Sahoo SK
    Int J Pharm; 2018 Mar; 538(1-2):263-278. PubMed ID: 29339248
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nanocarriers for the Delivery of Medical, Veterinary, and Agricultural Active Ingredients.
    Chariou PL; Ortega-Rivera OA; Steinmetz NF
    ACS Nano; 2020 Mar; 14(3):2678-2701. PubMed ID: 32125825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic Interplay of Medicinal Chemistry and Formulation Strategies in Nanotechnology - From Drug Discovery to Nanocarrier Design and Development.
    Sunoqrot S; Hamed R; Abdel-Halim H; Tarawneh O
    Curr Top Med Chem; 2017; 17(13):1451-1468. PubMed ID: 28017147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment.
    Milewska S; Niemirowicz-Laskowska K; Siemiaszko G; Nowicki P; Wilczewska AZ; Car H
    Int J Nanomedicine; 2021; 16():6593-6644. PubMed ID: 34611400
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances in siRNA delivery for cancer therapy using smart nanocarriers.
    Zhang P; An K; Duan X; Xu H; Li F; Xu F
    Drug Discov Today; 2018 Apr; 23(4):900-911. PubMed ID: 29373841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanotechnology in cancer therapy.
    Aslan B; Ozpolat B; Sood AK; Lopez-Berestein G
    J Drug Target; 2013 Dec; 21(10):904-13. PubMed ID: 24079419
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nano-Bio Interactions in Cancer: From Therapeutics Delivery to Early Detection.
    Liu Y; Wang J; Xiong Q; Hornburg D; Tao W; Farokhzad OC
    Acc Chem Res; 2021 Jan; 54(2):291-301. PubMed ID: 33180454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Injectable Drug-Loaded Nanocarriers for Lung Cancer Treatments.
    Yu HP; Aljuffali IA; Fang JY
    Curr Pharm Des; 2017; 23(3):481-494. PubMed ID: 28292243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The development of nanocarriers for natural products.
    Huang L; Luo S; Tong S; Lv Z; Wu J
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2024; 16(3):e1967. PubMed ID: 38757428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Smart cancer nanomedicine.
    van der Meel R; Sulheim E; Shi Y; Kiessling F; Mulder WJM; Lammers T
    Nat Nanotechnol; 2019 Nov; 14(11):1007-1017. PubMed ID: 31695150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: A synergistic combination nanotherapy for cervical cancer.
    Li C; Ge X; Wang L
    Biomed Pharmacother; 2017 Feb; 86():628-636. PubMed ID: 28027539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.